. Author manuscript; available in PMC: 2016 Apr 15.

Published in final edited form as: J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e69–e76. doi: 10.1097/QAI.0000000000000527

Table 2.

Prevalent and incident tuberculosis

		Screened for TB (N=540)	TB culture results available (N=343)	Positive TB culture (N=25)

Total Cases N (%)	Total	72 (13.3%)	49 (14.3%)	25 (100%)

	S+ PTB	18 (3.3%)	14 (4.1%)	10 (40.0%)
	S− PTB	29 (5.4%)	23 (6.7%)	14 (56.0%)
	EPTB	25 (4.6%)	12 (3.5%)	1 (4.0%)

Pre-ART (Baseline) N (%)	Total	59 (81.9%)	43 (87.8%)	25 (100%)

	S+ PTB	16 (22.2%)	13 (26.5%)	10 (40.0%)
	S− PTB	27 (37.5%)	23 (46.9%)	14 (56.0%)
	EPTB	16 (22.2%)	7 (14.3%)	1 (4.0%)

Post-ART N (%)	Total	13 (18.1%)	6 (12.2%)	0

	S+ PTB	2 (2.8%)	1 (2.0%)	0
	S− PTB	2 (2.8%)	0 (0.0%)	0
	EPTB	9 (12.5%)	5 (10.2%)	0

TB=tuberculosis; CrAg=serum cryptococcal antigen; S+ PTB=sputum smear-positive pulmonary TB; S− PTB: sputum smear-negative pulmonary TB; EPTB: extra-pulmonary TB; N=number